Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz, Alcon and Advanced Accelerator Applications to learn about our generics, eye care and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A C D E F G I J K L M N O P R S T U V X Z

Afinitor Disperz®/Votubia®

everolimus

Oncology

Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Afinitor®/Votubia®

everolimus

Oncology

Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Arzerra®

ofatumumab

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Azarga®/Azorga®

brinzolamide, timolol

Ophthalmology

Germany Australia Austria Poland Netherlands Canada Japan

Cibacen®

benazepril hydrochloride

Cardio-Metabolic

Established Medicines

Ciprodex®

ciprofloxacin, dexamethasone

Ophthalmology

Global Product Site Canada USA

Comtan®

entacapone

Neuroscience

Established Medicines

Global Product Site USA Australia Netherlands Canada Turkey Japan

Cosentyx®

secukinumab

Immunology and Dermatology

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Diovan HCT® /Co-Diovan®

valsartan, hydrochlorothiazide

Cardio-Metabolic

Established Medicines

USA Product Site USA Finland Austria Poland Netherlands Canada Turkey

Diovan®

valsartan

Cardio-Metabolic

Established Medicines

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey Japan

Duotrav™

travoprost, timolol

Ophthalmology

Germany Australia Austria Poland Netherlands Canada Japan

Durezol®

difluprednate

Ophthalmology

Global Product Site USA Canada

Entresto®

sacubitril, valsartan

Cardio-Metabolic

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Eucreas®

vildagliptin, metformin

Cardio-Metabolic

Respiratory

Global Product Site Finland United Kingdom Austria Poland Netherlands

Exelon®

rivastigmine

Neuroscience

Established Medicines

USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Exforge HCT®

valsartan, amlodipine besylate, hydrochlorothiazide

Cardio-Metabolic

Established Medicines

USA Product Site USA Finland Germany Australia Austria Poland Turkey Japan

Exforge®

valsartan, amlodipine besylate

Cardio-Metabolic

Established Medicines

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey

Exjade®

deferasirox

Oncology

Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Extavia®

interferon beta-1b

Neuroscience

USA Product Site USA Finland Germany United Kingdom Poland Canada

Farydak®

panobinostat

Oncology

Global Product Site USA Germany Novartis Oncology Netherlands Austria Poland Netherlands

Femara®

letrozole

Oncology

USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Netherlands Canada Turkey Japan

Focalin®

dexmethylphenidate HCl, dexmethylphenidate extended release

Neuroscience

Established Medicines

USA Product Site USA

Focalin® XR

dexmethylphenidate HCl, dexmethylphenidate extended release

Neuroscience

Established Medicines

USA Product Site USA

Galvus®

vildagliptin

Cardio-Metabolic

Established Medicines

Global Product Site Finland Australia United Kingdom Austria Poland Netherlands Turkey

Gilenya®

fingolimod

Neuroscience

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Gleevec®/Glivec®

imatinib mesylate

Oncology

Global Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Ilaris®

canakinumab

Immunology and Dermatology

USA Product Site USA Germany United Kingdom Austria Poland Netherlands Canada Turkey Japan

Ilevro®/Nevanac®

nepafenac

Ophthalmology

Global Product Site Germany Canada Australia Austria Poland Netherlands USA

Izba®

travoprost

Ophthalmology

Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Jadenu®

deferasirox

Oncology

Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Jakavi®

ruxolitinib

Oncology

Global Product Site Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Kisqali®

ribociclib

Oncology

Global Product Site USA Product Site

Kymriah™

tisagenlecleucel-T

Oncology

USA Product Site

Lamisil®

terbinafine (terbinafine hydrochloride)

Infectious disease

Established Medicines

USA Germany Australia United Kingdom Poland Canada Turkey

Lescol®

fluvastatin sodium

Cardio-Metabolic

Established Medicines

Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lescol® XL

fluvastatin sodium

Cardio-Metabolic

Established Medicines

Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lucentis®

ranibizumab

Ophthalmology

Global Product Site Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Mekinist®

trametinib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Myfortic®

mycophenolic acid (as mycophenolate sodium)

Immunology and Dermatology

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Neoral®/Sandimmune®

cyclosporine, USP Modified

Immunology and Dermatology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Onbrez® Breezhaler®

indacaterol

Respiratory

Finland Germany Australia United Kingdom Poland Netherlands Canada Turkey Japan

Pataday™

olopatadine

Ophthalmology

Global Product Site USA Canada

Patanol®

olopatadine

Ophthalmology

Global Product Site USA Product Site USA Australia Poland Netherlands Canada Japan

Pazeo®

olopatadine

Ophthalmology

Global Product Site USA Canada

Proleukin®

aldesleukin

Oncology

USA Product Site Germany United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Netherlands Canada Turkey

Promacta®/Revolade®

eltrombopag

Oncology

Global Product Site USA Product Site USA Finland Germany Australia Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

Ritalin LA®

methylphenidate HCl modified release

Neuroscience

Established Medicines

USA Australia

Ritalin®

methylphenidate HCl

Neuroscience

Established Medicines

Global Product Site USA Finland Germany Australia United Kingdom Austria Netherlands Canada Turkey Japan

Rydapt®

midostaurin

Oncology

Global Product Site USA Product Site

Sandostatin LAR®

octreotide acetate

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Sandostatin® SC

octreotide acetate

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Seebri Breezhaler®

glycopyrronium bromide

Respiratory

Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Signifor®

pasireotide

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Signifor® LAR

pasireotide

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Simbrinza®

brinzolamide, brimonidine tartrate

Ophthalmology

Global Product Site USA Germany Australia Austria Poland Netherlands Canada

Simulect®

basiliximab

Immunology and Dermatology

Global Product Site USA Finland Germany United Kingdom Austria Poland Netherlands Canada Turkey

Stalevo®

carbidopa, levodopa, entacapone

Neuroscience

Established Medicines

Global Product Site USA Australia Austria Netherlands Canada Turkey Japan

Systane®

polyethylene glycol 400, propylene glycol

Ophthalmology

Global Product Site

Systane® Balance

propylene glycol

Ophthalmology

Global Product Site

Systane® Hydration

polyethylene glycol 400, propylene glycol, hyaluronic acid

Ophthalmology

Global Product Site

Systane® Ultra

polyethylene glycol 400, propylene glycol

Ophthalmology

Global Product Site

Tafinlar®

dabrafenib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Tasigna®

nilotinib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Tegretol®

carbamazepine

Neuroscience

Established Medicines

Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

TOBI®

tobramycin

Respiratory

Established Medicines

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

TOBI® Podhaler™

tobramycin

Respiratory

Established Medicines

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tobradex®

tobramycin, dexamethasone

Ophthalmology

USA Germany Austria Poland Netherlands Canada

Travatan Z®

travoprost

Ophthalmology

Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan®

travoprost

Ophthalmology

Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan® BAK-Free

travoprost

Ophthalmology

Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Trileptal®

oxcarbazepine

Neuroscience

Established Medicines

Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Tyverb®

lapatinib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

Tyzeka®/Sebivo™

telbivudine

Infectious disease

Established Medicines

Global Product Site USA Germany United Kingdom Poland Canada Turkey

Ultibro® Breezhaler®

indacaterol, glycopyrronium bromide

Respiratory

Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Voltaren®/Cataflam®

diclofenac sodium, potassium, resinate, free acid

Autoimmunity, Transplantation & Inflammatory Disease

Established Medicines

Global Product Site Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Votrient®

pazopanib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Xolair®

omalizumab

Immunology and Dermatology

Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Zometa®

zoledronic acid

Oncology

USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Zortress®/Certican®

everolimus

Immunology and Dermatology

Global Product Site USA Product Site USA Germany Australia United Kingdom Austria Poland Netherlands Turkey

Zykadia™

ceritinib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey